What is BHRT and how do I know if I need it?

Short answer

• BHRT = bioidentical hormone replacement therapy. It uses hormones that are chemically identical to the hormones your body normally makes (estradiol, progesterone, testosterone, sometimes DHEA) to treat symptoms of hormone deficiency.
• Whether you “need” it depends on your symptoms, medical history, and risk factors — it’s something to discuss with a clinician after evaluation.

What BHRT means (brief)

• “Bioidentical” refers to the chemical structure being identical to human hormones (for example, 17β‑estradiol and micronized progesterone).
• BHRT can be prescribed as FDA‑approved products (many estradiol and micronized progesterone formulations are bioidentical) or as compounded custom preparations (creams, troches, pellets). Compounded products are not FDA‑regulated and vary in quality/dosing.

Who might consider BHRT

• Women with moderate–severe menopausal symptoms that affect quality of life: hot flashes/night sweats, sleep disruption, mood change, vaginal dryness/pain with intercourse.
• People with premature ovarian insufficiency or surgical menopause.
• People (including some transgender or nonbinary patients) being treated for gender‑affirming hormone needs — under specialist care.
• Men with clinically confirmed testosterone deficiency and symptoms (low libido, fatigue, muscle loss) — after appropriate evaluation.

How to know if you need it (practical steps)

1. Review symptoms: are vasomotor, sexual, sleep, mood, or genitourinary symptoms moderate–severe and persistent? If yes, hormone therapy is commonly considered.
2. See a clinician (primary care, gynecologist, or endocrinologist; or a menopause specialist). Bring a symptom history, medication list, and family history (breast cancer, blood clots, cardiovascular disease).
3. Expect baseline testing: routine labs (lipids, glucose/HbA1c, liver and kidney function), a pregnancy test if relevant, and targeted hormone tests if needed (morning total testosterone for men; FSH/estradiol can sometimes help in perimenopause but are not always necessary). Also make sure mammogram and cervical screening are up to date per guidelines.
4. Discuss risks vs benefits with your clinician based on age, time since menopause, personal/family risk for breast cancer, clotting disorders, stroke, or heart disease. (Timing matters: for many women within 10 years of menopause, benefits often outweigh risks.)
5. If hormone therapy is chosen, discuss route and product (transdermal patches/gels often have lower clot risk than oral estrogens; if you still have a uterus you will need progesterone or a combined product to protect the endometrium).

Risks and caveats

• Hormone therapy carries risks (breast cancer, blood clots, stroke, cardiovascular events) that vary by age, dose, formulation, and route.
• Marketing claims that compounded “bioidentical” hormones are safer or more effective are not proven; compounded products carry quality and dosing variability. Prefer FDA‑approved bioidentical products when possible.
• Pellets and some compounded regimens are increasingly used but have less predictable dosing and higher complication reports — discuss carefully.

Common FDA‑approved products (examples)

• Estradiol patches: Climara, Vivelle‑Dot (good for systemic vasomotor symptoms; transdermal route may have lower clot risk).
• Oral estradiol: Estrace.
• Vaginal estrogen (local therapy for dryness/urginal symptoms): Estring (ring), Vagifem (vaginal tablet), low‑dose creams — these act locally with lower systemic exposure.
• Micronized progesterone: Prometrium (used when uterus is intact).
• Testosterone products (for men: AndroGel; for women testosterone therapy is off‑label and needs specialist oversight).

How to proceed

• If you have bothersome symptoms, make an appointment with a clinician experienced in menopause/hormone therapy (board‑certified gynecologist, endocrinologist, or a menopause clinic). Good resources: North American Menopause Society (NAMS), Mayo Clinic, Cleveland Clinic patient pages.
• If a compounded product is considered, use a reputable, accredited compounding pharmacy (PCAB/ACHC accreditation or USP compliance) and get regular follow‑up and monitoring.

If you want, I can:

• Help you make a short symptom checklist to bring to your appointment, or
• List questions to ask your clinician about BHRT, risks, and monitoring, or
• Point you to specific, reputable clinics/telehealth services in your area. Which would be most helpful?